Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications.

What was recalled

Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01

Recalling firm: Mayne Pharma Inc
NDC code: 0574-0222-01
Origin: NC, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-0098-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Liothyronine recalls

See all

Class II · Moderate risk Terminated Dec 4, 2023

Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury…

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries INC NDC 62756-589-88 D-0150-2024

Class II · Moderate risk Terminated Oct 20, 2023